USAR Falls Below 50-Day SMA: Is It Time to Hold or Exit the Stock?

USA Rare Earth shares closed at $17.06 on Sept. 9, below both the 50-day SMA of $17.54 and 200-day SMA of $19.26, after falling 18.8% over six months. H1 2026 net loss widened to $77.3M, operating cash outflow reached $75.3M, and capex consumed $108.4M despite $11.5M of revenue and a negative 12.8% gross margin. While the Serra Verde combination and up to $1.6B in government-backed CHIPS funding support its mine-to-magnet strategy, execution risk, feedstock dependence, high cash burn and lower 2026 estimates underpin its Zacks Rank #4 (Sell).

Analysis

USAR's investability hinges less on moving averages than on financing chronology: its asset buildout is likely to consume capital materially ahead of any integrated-margin benefit. Government loan capacity is not equivalent to cash; milestone conditions, matching-capital requirements and permitting can create a funding gap that forces equity issuance precisely when the equity is weak. The Serra Verde transaction also adds integration, Brazilian operating and minority-interest complexity before it demonstrably reduces feedstock costs.

The competitive read-through is selectively favorable for MP. A US customer seeking secure NdFeB supply can value USAR as a second-source option, but USAR's delayed ramp increases the scarcity premium for MP's existing Mountain Pass-to-magnet capacity over the next 12-18 months. BHP has negligible direct exposure; its relative resilience reflects diversified cash generation rather than a comparable rare-earth thesis. The more relevant external variable is NdPr pricing: stronger prices improve USAR's future strategic narrative but may worsen its interim third-party feedstock economics.

Consensus may be too focused on operating losses while underweighting strategic optionality from a credible non-China supply chain. That optionality is real, but it should be priced as a dated call option rather than as current operating value. Near-term downside is most acute if the next results fail to disclose qualified magnet output, customer offtake terms, capex-to-completion and unrestricted liquidity; conversely, binding offtakes with prepayments or non-dilutive milestone funding would invalidate a tactical short.

Over the next 1-3 months, estimate cuts and any capital raise can pressure USAR disproportionately because its revenue base cannot absorb execution slippage. Over 6-18 months, commercial yield, qualification and feedstock security—not announced capacity—will determine whether its premium valuation can persist. A sustained recovery requires evidence that incremental revenue carries positive contribution margin, rather than merely expanding low-margin metal-making sales.

Key Decisions for Investors

• Maintain a tactical underweight/short USAR into the next earnings and financing update; use a close above $19.25 or disclosure of binding magnet offtakes plus funded capex as a thesis stop. Target a 15-25% downside over 1-3 months if dilution risk or ramp delays become explicit.
• Express the domestic rare-earth theme through long MP versus short USAR in dollar-neutral sizing for 6-12 months. MP has the nearer-term scarcity and execution advantage; cover the spread if USAR reports qualified commercial magnet shipments with positive gross margin or secured customer prepayments.
• Do not treat the announced government facility as deployable liquidity until loan milestones, draw timing, interest terms and required equity contribution are filed. Create an alert for a shelf registration, ATM program, convertible issuance or revised capex schedule; any of these would reinforce the USAR short.
• For investors requiring upside exposure to USAR's policy optionality, wait for independently disclosed production yield and customer qualification rather than buying the technical decline. A defined-risk call structure only becomes attractive after funding visibility improves, since unhedged equity can face serial dilution before the 6-18 month catalyst window.